Increased serum bone sialoprotein concentrations in patients with Crohn's disease;Erhöhte serum-bone-sialoprotein-konzentrationen bei patienten mit morbus Crohn

Zeitschrift fur Gastroenterologie

Volumn 41, Issue 3, 2003, Pages 243-247

  Faust, D ^a   Menge, F ^a   Armbruster, F P ^b   Lembcke, B ^c   Stein, J ^a  

^a GOETHE UNIVERSITY   (Germany)

^b IMMUNDIAGNOSTIK AG   (Germany)

^c St Barbara Hospital   (Germany)

Author keywords

Bone sialoprotein; Crohn's disease; Osteopenia

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; COLLAGEN TYPE 1; CORTICOSTEROID; DEOXYPYRIDINOLINE; PHOSPHATE; PROCOLLAGEN; SIALOPROTEIN; VITAMIN D;

ADULT; AGED; ARTICLE; BONE METABOLISM; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CROHN DISEASE; CROSS LINKING; CYTOKINE RELEASE; DRUG BONE LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; HUMAN; MALE; OSTEOPENIA; PATHOGENESIS; RADIOIMMUNOASSAY;

ADULT; BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; BONE RESORPTION; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOIMMUNOASSAY; SIALOGLYCOPROTEINS;

EID: 0037351092     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37901     Document Type: Article

References (44)

1. Andreassen H, Rungby J, Dahlerup JF et al. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997; 32: 1247-1255
2. Bischoff SC, Herrmann A, Goke M et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997; 92: 1157-1163
3. Gasche C. Complications of inflammatory bowel disease. Hepatogastroenterology 2000; 47: 49-56
4. Cowan FJ, Warner JT, Dunstan FD et al. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997; 76: 325-329
5. Adachi JD, Rostom A. Metabolic bone disease in adults with inflammatory bowel disease. Inflamm Bowel Dis 1999; 5: 200-211
6. Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol 2001; 33: 289-294
7. Habtezion A, Silverberg MS, Parkes R et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002; 8: 87-92
8. Compston JE, Judd D, Crawley EO et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 410-415
9. Ghosh S, Cowen S, Hannah WJ et al. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107: 1031-1039
10. Bjarnason I, Macpherson A, Mackintosh C et al. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40: 228-233
11. Compston JE. Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995; 9: 237-250
12. Andreassen H, Rix M, Brot C et al. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol 1998; 33: 1087-1093
13. von Tirpitz C, Pischulti G, Klaus J et al. Pathological bone density in chronic inflammatory bowel diseases - prevalence and risk factors. Z Gastroenterol 1999; 37: 5-12
14. Schreiber S, Heinig T, Thiele HG et al. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 1434-1444
15. Fassbender WJ, Ruf T, Kaiser HE et al. Serum levels of immunoreactive bone sialoprotein in osteoporosis: positive relations to established biochemical parameters of bone turnover. In Vivo 2000; 14: 619-624
16. Shaarawy M, Hasan M. Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis. Scand J Clin Lab Invest 2001; 61: 513-521
17. Woitge HW, Pecherstorfer M, Horn E et al. Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. Br J Cancer 2001; 84: 344-351
18. Withold W, Armbruster FP, Karmatschek M et al. Bone sialoprotein in serum of patients with malignant bone diseases. Clin Chem 1997; 43: 85-91
19. Mansson B, Carey D, Alini M et al. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995; 95: 1071-1077
20. Fall PM, Kennedy D, Smith JA et al. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men. Osteoporos Int 2000; 11: 481-485
21. Pietschmann P, Kudlacek S, Grisar J et al. Bone turnover markers and sex hormones in men with idiopathic osteoporosis. Eur J Clin Invest 2001; 31: 444-451
22. Karmatschek M, Maier I, Seibel MJ et al. Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay. Clin Chem 1997; 43: 2076-2082
23. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979; 77: 843-846
24. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298: 82-86
25. Bischoff SC, Herrmann A, Goeke M et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997; 92: 1157-1163
26. Bjarnason I, Macpherson A, Mackintosh C et al. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40: 228-233
27. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995; 332: 305-311
28. Issenman RM. Bones in Crohn's: cytokines, a missing link? J Pediatr Gastroenterol Nutr 1997; 24: 361-362
29. Cominelli F, Pizarro TT. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment Pharmacol Ther 1996; 10 (Suppl 2): 49-53
30. Schulte CM, Dignass AU, Goebell H et al. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 2000; 119: 909-920
31. Abitbol V, Roux C, Chaussade S et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417-422
32. Compston JE. Can biochemical markers be used to screen patients with inflammatory bowel disease for osteoporosis? Eur J Gastroenterol Hepatol 2002; 14: 587-589
33. Jahnsen J, Falch JA, Aadland E et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997; 40: 313-319
34. Robinson RJ, Iqbal SJ, Abrams K et al. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998; 12: 699-705
35. Bernstein CN. Determinants of bone density in inflammatory bowel disease. Gastroenterology 1995; 108: 1607-1609
36. Schulte C, Dignass AU, Mann K et al. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study. Scand J Gastroenterol 1999; 34: 696-702
37. Schulte C, Dignass AU, Mann K et al. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 1998; 4: 268-275
38. Schoon EJ, Geerling BG, van Dooren IM et al. Abnormal bone turnover in long-standing Crohn's disease in remission. Aliment Pharmacol Ther 2001; 15: 783-792
39. Schoon EJ, Blok BM, Geerling BJ et al. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 2000; 119: 1203-1208
40. Faust D, Raschke K, Hormann S et al. Regulation of alpha 1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells. Clin Exp Immunol 2002; 128: 279-284
41. Schulte C, Goebell H, Roher HD et al. Genetic determinants of 1L-6 expression levels do not influence bone loss in inflammatory bowel disease. Dig Dis Sci 2001; 46: 2521-2528
42. Hacker UT, Bidlingmaier C, Gomolka M et al. Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms. Eur J Clin Invest 1998; 28: 214-219
43. Hyams JS, Wyzga N, Kreutzer DL et al. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr 1997; 24: 289-295
44. Al Awadhi A, Olusi S, Al Zaid N et al. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 1250-1256